In Vitro and In Vivo Antibacterial Activities of Omadacycline, a Novel Aminomethylcycline

Omadacycline is the first intravenous and oral 9-aminomethylcycline in clinical development for use against multiple infectious diseases including acute bacterial skin and skin structure infections (ABSSSI), community-acquired bacterial pneumonia (CABP), and urinary tract infections (UTI). The compa...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Macone, A. B., Caruso, B. K., Leahy, R. G., Donatelli, J., Weir, S., Draper, M. P., Tanaka, S. K., Levy, S. B.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2014
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910882/
https://ncbi.nlm.nih.gov/pubmed/24295985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01242-13
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires